Visit Ortho Clinical Diagnostics at booth #1102 during the 2008 AABB Annual Meeting and TXPO in Montreal, October 4-7.
Come see the possibilities:
| + |
See why a majority of Blood Banks in North America have chosen ID-MTS™ Gel to meet
their blood typing and antibody identification needs
|
| + |
Discover how over 550 blood banks in North America have automated with confidence using
ORTHO ProVue®
|
| + |
Learn how RhoGAM® Brand Rho(D) Immune Globulin (Human) has been protecting
Rh-negative mothers for 40 years
|
| + |
Come see the Ortho Verseia™ Pipetter* and find out what’s new in the Ortho Summit™
System for donor screening
|
| + |
See why the ORTHO AutoVue® System** is recognized as the international industry standard
for full automation, with 250 million tests performed annually
|
| + |
Experience the quality and productivity of the VITROS® 3600 Immunodiagnostic System***
and discover what true integration by design can do for your laboratory |
Booth hours
October 4 5:30 p.m. - 8 p.m.
October 5 Noon - 6 p.m.
October 6 10 a.m. - 4 p.m.
October 7 10 a.m. - 2 p.m.
- Abstracts
-
| + |
A Diagnostic Assay for Detection of Antibodies to Trypanosoma cruzi
|
| + |
Improved Sensitivity of the ORTHO® T. cruzi ELISA Test System
|
| + |
Prevalence of Trypanosoma cruzi Antibodies in Blood Donors from Presumed High-Risk Regions
of the United States Using the ORTHO® T. cruzi ELISA Test System
|
| + |
Expanded Product Claims for Blood Collection Device Types and Sample Stability with the
ORTHO® HCV Version 3.0 ELISA Test System
|
| + |
Expanded Product Claims for Potentially Interfering Substances with the ORTHO® HCV Version
3.0 ELISA Test System
|
| + |
Cadaveric Specimen Performance Evaluation Using the ORTHO® HCV Version 3.0 ELISA Test System
|
| + |
Cadaveric Specimen Performance Evaluation Using the ORTHO ®T. cruzi ELISA Test System
|
| + |
ORTHO® HCV Version 3.0 Test System Equipment Evaluation |
- More information from the AABB
* In development.
** Not available in North America.
*** In development. Not intended for Donor Screening use in the U.S.